Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Bonds: Convertible Notes, Reduced, 2024 Q4

CITADEL ADVISORS LLC historic quarter change: USA Bonds: Convertible Notes, Reduced

In convertible notes that pay a coupon (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 1,005 positions, added to 266, reduced 334 and sold out of 965.

  • Q4 2024: Stock NUTANIX INC; Country of operation United States; Class NOTE 0.250%10/0; Principal before $30,000,000.
  • Q4 2024: Stock IMPINJ INC; Country of operation —; Class NOTE 1.125% 5/1; Principal before $46,100,000.
  • Q4 2024: Stock HALOZYME THERAPEUTICS INC; Country of operation United States; Class NOTE 1.000% 8/1; Principal before $58,371,000.
  • Q4 2024: Stock LIBERTY MEDIA CORP DEL; Country of operation —; Class NOTE 3.750% 3/1; Principal before $25,000,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassPrincipal beforePrincipal afterShare changeValue beforeValue afterValue changeFiled
Q4 2024NUTANIX INC
CUSIP 67059NAH1
United StatesNOTE 0.250%10/0$30,000,000$6,000,000-24,000,000$35,888,953$7,253,932-$28,635,0212025-02-14
Q4 2024IMPINJ INC
CUSIP 453204AD1
—NOTE 1.125% 5/1$46,100,000$45,000,000-1,100,000$92,353,747$63,990,000-$28,363,7472025-02-14
Q4 2024HALOZYME THERAPEUTICS INC
CUSIP 40637HAF6
United StatesNOTE 1.000% 8/1$58,371,000$38,371,000-20,000,000$69,524,602$41,536,690-$27,987,9122025-02-14
Q4 2024LIBERTY MEDIA CORP DEL
CUSIP 531229AP7
—NOTE 3.750% 3/1$25,000,000$7,000,000-18,000,000$25,855,232$7,246,283-$18,608,9492025-02-14
Q4 2024VEECO INSTRS INC DEL
CUSIP 922417AJ9
—NOTE 2.875% 6/0$30,000,000$20,000,000-10,000,000$40,724,809$23,944,751-$16,780,0582025-02-14
Q4 2024WAYFAIR INC
CUSIP 94419LAR2
—NOTE 3.500%11/1$37,500,000$36,500,000-1,000,000$55,203,254$45,451,133-$9,752,1212025-02-14
Q4 2024HCI GROUP INC
CUSIP 40416EAF0
—NOTE 4.750% 6/0$20,000,000$15,000,000-5,000,000$28,986,039$23,082,109-$5,903,9302025-02-14
Q4 2024PAR TECHNOLOGY CORP
CUSIP 698884AE3
—NOTE 1.500%10/1$18,500,000$17,500,000-1,000,000$18,449,709$20,185,367+$1,735,6582025-02-14
Q4 2024DYNAVAX TECHNOLOGIES CORP
CUSIP 268158AD4
—NOTE 2.500% 5/1$40,119,000$36,369,000-3,750,000$48,868,954$47,790,700-$1,078,2542025-02-14
Q4 2024ENCORE CAP GROUP INC
CUSIP 292554AM4
—NOTE 3.250%10/0$9,000,000$8,250,000-750,000$11,497,500$10,578,142-$919,3582025-02-14